本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Fulcrum Therapeutics

6.88
+0.28004.24%
盘后6.880.00000.00%16:21 EDT
成交量:104.02万
成交额:713.00万
市值:3.71亿
市盈率:-837.90
高:7.06
开:6.69
低:6.31
收:6.60
数据加载中...
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/24

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/15

重要事件披露

Form 8-K - Current report
2023/04/05

重要事件披露

8-K - Current report
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/06

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/18

重要事件披露

8-K - Current report